Ostabolin (Zelos)

N/A

Report date: 2023/02/04 20:21:34

Base Information

Drug NameOstabolin (Zelos)

Drug Alias NameOstabolin injectionParathyroid hormone analogue injection-Azelon PharmaceuticalsOstabolin-C injection-Azelon PharmaceuticalsCyclic hPTH-(1-31)-NH2 injectionOstabolin-C injectable +[8]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionOsteogenesis stimulantsParathyroid hormone receptor agonists

TargetsParathyroid hormone receptor

Therapy Area/IndicationsMenopausal symptomsHip FracturesChronic Kidney Disease-Mineral and Bone Disorder +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAzelon Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAzelon Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsMenopausal symptomsHip FracturesChronic Kidney Disease-Mineral and Bone Disorder +[5]

Other Information

ATC CodeN/A